HCPCS codes / Q / Q0180
Q0180
Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
- Code type
- HCPCS Level II
- Coverage
- Special coverage instructions
- BETOS category
- O1D
- Pricing indicator
- 51
- Effective date
- 19980401
Verify before billing. Confirm against current official CMS HCPCS files and your payer's rules before clinical or claims use.